Central precocious puberty is associated with both psychological and physical sequelae. Long-acting gonadotropin-releasing hormone analogs are currently used as the therapy of choice for central precocious puberty. The current diagnostic and therapeutic approaches to management of precocious puberty are summarized, and controversial issues that require future study are discussed.